What the session covered
In this Friday Focus call, Mark and Tarek, co-founders of Fablo.ai, discussed AI-supported pre-submission review under the MDR. They began with the practical problems that delay technical documentation assessment, including incomplete submissions, poor document structure, inconsistent information across files, and file naming that makes retrieval difficult. They linked these points to the April 2026 Team-NB guidance update and its recommendations on reviewability, complete and up-to-date reports, GSPR traceability, and consistency of key device information.
Tarek used a blood pressure monitor example to show how documents can look consistent at summary level but still contain a gap. The instructions for use covered patients aged 12 and over, while the clinical evaluation report study cohort covered ages 18 to 75. He then demonstrated Fablo's regulatory readiness review, showing how uploaded documents are checked for gaps, missing evidence, and cross-document links, with findings left for a regulatory expert to accept or reject.
The speakers set out a three-step model: the regulatory team defines scope, AI analyses documentation and highlights potential issues, and the expert validates findings. They also discussed evidence traceability, prioritisation of findings, and a longer-term move towards continuous regulatory readiness. In Q&A they described pilot work with manufacturers, a subscription model, and early discussions with notified bodies. The main takeaway was that complete documentation does not guarantee sufficient evidence, and human judgement remains essential.
Full recording
52:54Plays from YouTube when you press play. Cookie settings
How to cite this session
Gerlach, M., Sreedharan, T. (2026, October 30). AI Pre-Submission Review Under the MDR [Webinar]. MedTech Leading Voice, Friday In-Focus. medtechleadingvoice.com/watch/2026-10-30-ai-pre-submission-review-under-the-mdr